Hanai Tatsunori, Shiraki Makoto, Imai Kenji, Suetsugu Atsushi, Takai Koji, Moriwaki Hisataka, Shimizu Masahito
Department of Gastroenterology/Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
Division for Regional Cancer Control, Gifu University Graduate School of Medicine, Gifu, Japan.
Hepatol Res. 2019 Dec;49(12):1414-1426. doi: 10.1111/hepr.13420. Epub 2019 Oct 9.
Handgrip strength (HGS) is a marker of sarcopenia and has been used to stratify an individual's risk of death. We aimed to assess the prognostic significance of HGS in patients with liver cirrhosis.
In this retrospective study, we collated data of 563 consecutive patients admitted to our hospital with cirrhosis (375 men). A dynamometer was used to measure HGS. Body composition (including skeletal muscle and adipose tissue volumes) was estimated using computed tomography. Predictors of mortality were identified using sex-stratified multivariate analyses.
After adjustments for age, cirrhosis etiology, Child-Pugh score, and other confounding variables, HGS, but not body composition, was independently associated with mortality in male patients (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.94-0.99; P < 0.01) and female patients (HR, 0.91; 95% CI, 0.84-0.99; P = 0.02). Men with low HGS (<30 kg) had a higher risk of mortality (HR, 2.09; 95% CI, 1.39-3.17; P < 0.001), as did women with low (<15 kg) HGS (HR, 2.14; 95% CI, 1.16-4.01; P = 0.02). We could stratify the sex-specific risk of mortality in cirrhotic patients using HGS, regardless of coexistent hepatocellular carcinoma and the Child-Pugh class.
Reduced HGS, rather than skeletal muscle and adipose tissue volumes, is associated with an increased risk of mortality in patients of both sexes with liver cirrhosis. Measurement of HGS is a simple, cost-effective, and appropriate bedside assessment for the prediction of survival in patients with cirrhosis.
握力(HGS)是肌肉减少症的一个指标,已被用于对个体的死亡风险进行分层。我们旨在评估HGS在肝硬化患者中的预后意义。
在这项回顾性研究中,我们整理了我院连续收治的563例肝硬化患者(375例男性)的数据。使用测力计测量HGS。利用计算机断层扫描估计身体成分(包括骨骼肌和脂肪组织体积)。通过性别分层多变量分析确定死亡率的预测因素。
在对年龄、肝硬化病因、Child-Pugh评分和其他混杂变量进行调整后,HGS而非身体成分与男性患者(风险比[HR],0.96;95%置信区间[CI],0.94 - 0.99;P < 0.01)和女性患者(HR,0.91;95% CI,0.84 - 0.99;P = 0.02)的死亡率独立相关。HGS低(<30 kg)的男性死亡率风险更高(HR,2.09;95% CI,1.39 - 3.17;P < 0.001),HGS低(<15 kg)的女性也是如此(HR,2.14;95% CI,1.16 - 4.01;P = 0.02)。无论是否存在肝细胞癌和Child-Pugh分级,我们都可以使用HGS对肝硬化患者的性别特异性死亡风险进行分层。
HGS降低而非骨骼肌和脂肪组织体积增加与男女肝硬化患者的死亡风险增加相关。测量HGS是一种简单、经济有效且合适的床边评估方法,可用于预测肝硬化患者的生存率。